Price $46.13 |
Market Cap
885.8M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
85.3
|
P/B
4.95
|
P/S
16.68
|
Dividend %
0.50%
|
|
P/CF
118.2
|
P/FCF
66.2
|
Op. Cash Flow
19K
|
FCF
0.6
|
|
Op. Margin
22.20%
|
Net Margin
20.00%
|
ROE
6.00%
|
ROI
6.70%
|
|
ROA
5.70%
|
EPS Growth
3.00%
|
Current Ratio
19.1
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Puma Biotechnology Inc (PBYI) | $3.27 | - | - | 133.9M | Strong Buy |
| Bausch Health Companies Inc (BHC) | $8.19 | - | - | 2.78B | Strong Buy |
| Baudax Bio Inc (BXRX) | $0.52 | - | - | 4.4M | Strong Buy |
| Eton Pharmaceuticals Inc (ETON) | $3.86 | - | - | 101.3M | Strong Buy |
| Spero Therapeutics Inc (SPRO) | $1.77 | - | - | 74.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
